John P. Engels
Chief Executive Officer at CorMatrix Cardiovascular, Inc.
Profile
John P.
Engels founded AxoGen Corp.
in 2002, where he worked as Vice President from 2009 to 2010 and CorMatrix Cardiovascular, Inc. in 2023, where he is working as Chief Executive & Financial Officer, Secretary from 2023.
Mr. Engels also formerly worked at OxiCool, Inc., as Director, Synogen, Inc., as Consulting Associate, and Axogen, Inc., as Vice President from 2011 to 2018.
Mr. Engels received his undergraduate degree from The University of Chicago and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
John P. Engels active positions
| Companies | Position | Start |
|---|---|---|
CorMatrix Cardiovascular, Inc.
 CorMatrix Cardiovascular, Inc. Medical SpecialtiesHealth Technology CorMatrix Cardiovascular, Inc. develops and markets commercial medical devices. It offers CorMatrix CanGaroo, Vascular Repair, Pericardial Repair & Reconstruction, Tyke, and Cardiac Tissue Repair. The company was founded by David B. Camp and Robert G. Matheny in 2001 and is headquartered in Roswell, GA. | Chief Executive Officer | 2023-01-01 |
Former positions of John P. Engels
| Companies | Position | End |
|---|---|---|
| AXOGEN, INC. | Corporate Officer/Principal | 2017-12-31 |
Synogen Development Group LLC
 Synogen Development Group LLC Investment ManagersFinance Synogen Inc (Synogen) is a venture capital firm founded in 2003 by Jamie M. Grooms and Richard R. Allen. The firm is headquartered in Gainesville, Florida. | Corporate Officer/Principal | - |
AxoGen Corp.
 AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | Founder | 2011-10-12 |
OxiCool, Inc.
 OxiCool, Inc. Miscellaneous Commercial ServicesCommercial Services OxiCool, Inc. develops air conditioning technologies that are free of greenhouse gas based refrigerants for broad commercial and military applications. The company was founded by Ravikant Barot in 2006 and is headquartered in Malvern, PA. | Director/Board Member | - |
Training of John P. Engels
| The University of Chicago | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AXOGEN, INC. | Health Technology |
| Private companies | 4 |
|---|---|
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | Health Technology |
Synogen Development Group LLC
Synogen Development Group LLC Investment ManagersFinance Synogen Inc (Synogen) is a venture capital firm founded in 2003 by Jamie M. Grooms and Richard R. Allen. The firm is headquartered in Gainesville, Florida. | Finance |
OxiCool, Inc.
OxiCool, Inc. Miscellaneous Commercial ServicesCommercial Services OxiCool, Inc. develops air conditioning technologies that are free of greenhouse gas based refrigerants for broad commercial and military applications. The company was founded by Ravikant Barot in 2006 and is headquartered in Malvern, PA. | Commercial Services |
CorMatrix Cardiovascular, Inc.
CorMatrix Cardiovascular, Inc. Medical SpecialtiesHealth Technology CorMatrix Cardiovascular, Inc. develops and markets commercial medical devices. It offers CorMatrix CanGaroo, Vascular Repair, Pericardial Repair & Reconstruction, Tyke, and Cardiac Tissue Repair. The company was founded by David B. Camp and Robert G. Matheny in 2001 and is headquartered in Roswell, GA. | Health Technology |
- Stock Market
- Insiders
- John P. Engels
